Global Pitch Fest 2017

Watch Swiss startup representatives, the Venture Leaders in Life Sciences challenge local entrepreneurs at our legendary Global Pitch Fest – on a boat!

Event Details

Location

The Majesty
Long Wharf , Boston, Massachusetts 02109 United States

Date

June 15, 2017 from 5:00 pm to 9:00 pm

Cost


Come sail through the Boston Harbor with us and watch the Venture Leaders in Life Science challenge local entrepreneurs at the Global Pitch Fest! This year we will rock the boat again during this off-the-hook competition. Who will navigate their way to the top? You are at the helm along with our panel of judges to decide the winner!

Hopping on board not only allows you to hear (and judge!) the latest life sciences startup ideas from both sides of the Atlantic, but will also give you the opportunity to network and mingle with fellow entrepreneurs and innovation aficionados – a delicious catered reception and open bar comes with your ticket!

Last year’s event sold out so make sure to get your tickets ASAP and also take advantage of our Early Bird Pricing

Still not convinced? See pictures from last year!

Event Information

  • Date: Thursday, June 15
  • Time: Boarding 5:00 pm, Cruising 6:00-9:00 pm
  • Location: On Board of the Majesty (Docking at Long Wharf, Boston)
  • What: Global Pitch Competition, Networking Reception (feat. Barbara Lynch catering & open bar)

Join us for an evening aboard the Majesty in the good company of Switzerland’s premiere life sciences startups!
Get your ticket* while they last!

*Pre-sale only, no on-site purchase.


About the Venture Leaders:

Comphya, Rodrigo Araujo Fraga da Silva (Medtech, EPFL)
Comphya develops an active implantable medical device to restore the erectile function of patients who are non-responsive to oral drugs (e.g. Viagra or Cialis). To achieve erection, these patients have access to problematic and outdated methods such as intrapenile injections of vasodilators or penile implants. Comphya fills the need for better modalities for these patients, with a main focus on spinal cord injury and prostatectomy patients, both large segments with high potential of use.

Dicronis, Patrizia Marschalkova (Medtech, ETHZ) www.dicronis.ch
Lymphedema is a frequently occurring and serious complication of cancer therapies. It is a chronic and progressive disease, mostly outlined by the swelling of a limb due to improper function of the lymphatic system. Dicronis helps to drastically improve its prognosis by providing the earliest lymphedema diagnostic based on a micro-needles technology used to assess the lymphatic function in a simple, safe, minimally-invasive and cost-effective manner.

Dispencell, Georges Muller (Biotech, EPFL)
Biotech companies spend USD 220 million per year in isolating the best candidate living cell for making new drugs. With the technology of Dispencell, they will be able to isolate single cell lines three times faster and ten times cheaper than with existing solutions.

Lumigbo, Andreas Schmocker (Medtech, EPFL)
Every day, more than 1 million implants are placed using open surgery. Lumigbo developed a technology to build up implants inside the body using an access channel of less than half a millimeter in diameter. The procedure can be used for almost any type of polymer-based implant.

MaxWell BioSystems, Urs Frey (Micro technologies, Biotech, ETHZ) www.mxwbio.com
MaxWell Biosystems develops and distributes the most advanced electrophysiology cell-imaging platform for high-throughput assays to accelerate drug development. The toolset, consisting of an integrated sensor chip, acquisition hardware and software, delivers unprecedentedly accurate results. This solution can advance and accelerate drug discovery and basic neurosciences.

Medical Templates, Rafael Hostettler (Medtech, ETHZ) www.medicaltemplates.ch
Medical Templates developed the “Puncture Cube”, an ingeniously simple approach to computed tomography guided needle navigation in the body for biopsies and pain therapy. Targeted at interventional radiologists, the technology reduces radiation, intervention time and variance, while increasing patient comfort and safety. The solution has seen extremely positive user feedback. MedicalTemplates is now aiming towards FDA approval by the End of 2017 to enter the US market.

RetinAI Medical, Carlos Ciller (Medtech, UNIL) www.retinai.com
RetinAI Medical is a startup based in Bern, Switzerland, focused on empowering eye care professionals and doctors using artificial intelligence. RetinAI uses the latest machine learning techniques (deep learning) and medical image processing to reach human-level performance for the assisted automatic evaluation of Optical Coherence Tomography (OCT), Fundus Image Photography and retinal Angiography. These techniques can be applied to the early detection and screening of the following pathologies: Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and a multitude of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).

SensArs, Francesco Petrini (Medtech, EPFL) www.sensars.com
Lower limb amputees suffer from a lack of sensory feedback from prostheses. Because of this, they experience falls due to unexpected perturbations, and walk asymmetrically facing high fatigue. Also, they feel the prosthesis as a foreign body and contract phantom limb pain. Due to such inconveniences, 60% of the amputees abandon their prosthesis. SensArs’ solution is SENSY, a unique worldwide product which allows amputees to naturally feel their missing limbs.

SonoView, Ivana Balic (Medtech, EPFL) www.sono-view.com
SonoView develops an accurate, safe and cost-effective imaging technology to help health professionals detect breast cancer at an earlier and more treatable stage. The technology aims at obtaining the same image quality as Magnetic Resonance Scanning at one tenth of its cost.

SUINCoL, Mattias Larsson (Biotech, EPFL) 
SUINCoL develops tissue regeneration therapies, with the primary focus on non-invasive treatment of stress urinary incontinence. SUINCoL’s main goal is to motivate investors to fund further development of its products and their respective clinical introduction.


Interested in pitching?

Did you (or someone you know) recently launch a life sciences startup in the Boston area and want to fine-tune your pitch, whilst getting visibility for your business? Join our lineup of presenters!

Apply here or send an email to Philippe at philippe@nullswissnexboston.org.

 

Top